Percutaneous Coronary Intervention

ATLANTA — Among patients with ACS and a history of cocaine use, non-Hispanic Black patients were less likely than white patients to receive cardiac catheterization or revascularization, researchers reported.

ATLANTA — The monthly rate of PCI for STEMI dropped steadily at the start of the COVID-19 pandemic and has yet to return to pre-pandemic levels, according to a speaker.

ATLANTA — Clopidogrel monotherapy after 12 months of event free post-PCI dual antiplatelet therapy was associated with fewer MACCE and bleeding events vs. aspirin monotherapy in high bleeding risk patients, a speaker reported.

Sodium thiosulfate before and after STEMI for ischemia/reperfusion injury.

ATLANTA — In patients with calcified peripheral artery disease undergoing drug-coated balloon treatment, preparing the vessel with IV lithotripsy conferred better 1-year outcomes vs. preparing it with percutaneous transluminal angioplasty.

ATLANTA — Thirty-day hand function did not differ following distal radial artery access compared with proximal radial access PCI, researchers reported.

In patients with high bleeding risk who underwent complex PCI, dual antiplatelet therapy for approximately 1 month reduced bleeding compared with slightly longer DAPT duration, according to new data from the MASTER DAPT trial.

The rate of forearm radial artery occlusion was “extremely low” after conventional transradial and distal radial access, whereas distal access was associated with higher crossover rate but a shorter hemostasis time, researchers reported.

The Society for Cardiovascular Angiography and Interventions announced its 2022 Master Interventionalists of SCAI designations, which will be formally recognized during the SCAI Scientific Sessions in Atlanta on May 21, 2022.

Medtronic announced it received FDA approval for its next generation drug-eluting stent.